(Press-News.org) In what promises to be an eye-opener for many doctors and patients who routinely depend on cholesterol testing, a study led by researchers at the Johns Hopkins University School of Medicine found that the standard formula used for decades to calculate low-density lipoprotein (LDL) cholesterol levels is often inaccurate. Of most concern, the researchers say, is their finding that the widely used formula underestimates LDL where accuracy matters most — in the range considered desirable for high-risk patients. Results of the study are published in an online article, ahead of print, in the Journal of the American College of Cardiology.
LDL is known as the "bad" cholesterol, with higher numbers signaling greater risk of plaque accumulating in heart arteries and having a heart attack. Since 1972, a formula called the Friedewald equation has been used to gauge LDL cholesterol. It is an estimate rather than an exact measurement. However, physicians use the number to assess their patients' risk and determine the best course of treatment.
"In our study, we compared samples assessed using the Friedewald equation with a direct calculation of the LDL cholesterol. We found that in nearly one out of four samples in the 'desirable' range for people with a higher heart disease risk, the Friedewald equation had it wrong," says Seth Martin, M.D., a clinical fellow at the Johns Hopkins Ciccarone Center for the Prevention of Heart Disease. "As a result, many patients may think they achieved their LDL cholesterol target when, in fact, they may need more aggressive treatment to reduce their heart disease risk," says Martin, who is the lead author of the study.
"In patients with heart disease, we want to get their LDL level below 70 — that is the typical goal," says Steven Jones, M.D., director of inpatient cardiology at The Johns Hopkins Hospital and a faculty member at the Ciccarone Center who is the senior author of the study. Jones says based on their findings, many people — especially those with high triglyceride levels — may have a false sense of assurance that their LDL cholesterol targets have been met.
For the study, the researchers obtained detailed lipid profiles of more than 1.3 million American adults — almost one out of every 180 adults in the United States — analyzed from 2009 to 2011. The LDL cholesterol and other blood lipid components in those samples had been directly measured with a technique known as ultracentrifugation. The researchers then evaluated those samples using the Friedewald equation that is used routinely in doctors' offices worldwide. When they compared the results, the differences came to light.
The lipid profiles were from a laboratory in Birmingham, Alabama, that provides a detailed analysis of samples sent in by doctors across the country. Except for the age of people on whom the samples were based (59 years on average) and the gender (52 percent of the samples were from women), the patients were not identifiable to the researchers. The researchers collaborated with the lab to develop the database they would need for the study.
The Friedewald equation was introduced into clinical practice by William Friedewald, M.D., to work around the significant time and expense of ultracentrifugation specifically to measure LDL cholesterol among about 400 people in families with genetic cholesterol abnormalities. The equation calculates LDL cholesterol with the following formula: total cholesterol minus HDL cholesterol minus triglycerides divided by five. The result is expressed in milligrams per deciliter.
"The database that we used was almost 3,000 times larger than the sample used to devise the Friedewald equation," Martin says.
As an alternative to Friedewald, Martin and his colleagues suggest that a more accurate way to assess risk for patients is to look at non-HDL, which is acquired by subtracting HDL from total cholesterol.
That non-HDL number, which includes LDL and other plaque-causing cholesterol particles called VLDL (very low density lipoprotein), would typically be about 30 points higher than when LDL cholesterol is calculated under the Friedewald method, and it could vary. But Martin says it would provide a better way to assess whether patients need to modify their medications or make more substantial lifestyle changes. "Most specialists in our field agree at this point that all of those non-HDL components are important," he says.
The non-HDL cholesterol level can be obtained easily using the same test widely available in doctors' offices today at no greater cost than the Friedewald calculation.
"Non-HDL cholesterol is a much better target for quantifying risk of plaques in coronary arteries," says Jones. "Looking at non-HDL cholesterol would make it simpler and more consistent, and would enable us to provide our patients with a better assessment," he says.
Jones, who originated the idea to use the large laboratory database to assess the Friedewald equation, says the information was provided by the lab at no cost. The lab, Atherotech, did not provide any funding for the research. The database used in the study is registered on the website http://www.clinicaltrials.gov and will be an important resource for ongoing scientific investigation.
###
--JHM--
In addition to Martin and Jones, other researchers on the study, "Friedewald Estimated versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications" were:
Michael J. Blaha, Mohamed B. Elshazly, John W. McEvoy, Parag H. Joshi, Peter O. Kwiterovich, Andrew P. DeFilippis and Roger S. Blumenthal from Johns Hopkins; Eliot A. Brinton from the Utah Foundation for Biomedical Research and Utah Lipid Center; Peter P. Toth from the University of Illinois College of Medicine at Peoria; and Krishnaji R. Kulkarni and Patrick D. Mize from Atherotech Diagnostics Lab, in Birmingham, Ala.
COMMONLY USED CHOLESTEROL CALCULATION UNDERESTIMATES THE HEART DISEASE DANGER FOR MANY AT HIGH RISK, STUDY FINDS
Johns Hopkins Medicine
Media Relations and Public Affairs
Media Contacts:
Ellen Beth Levitt, 410-598-4711 (cell)
Helen Jones, hjones49@jhmi.edu, 410-502-9422
(Santa Barbara, Calif.) –– If you think your inability to concentrate is a hopeless condition, think again –– and breathe, and focus. According to a study by researchers at the UC Santa Barbara, as little as two weeks of mindfulness training can significantly improve one's reading comprehension, working memory capacity, and ability to focus.
Their findings were recently published online in the empirical psychology journal Psychological Science.
"What surprised me the most was actually the clarity of the results," said Michael Mrazek, graduate student researcher in psychology ...
MINNEAPOLIS – The virus that causes cold sores, along with other viral or bacterial infections, may be associated with cognitive problems, according to a new study published in the March 26, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology.
The study found that people who have had higher levels of infection in their blood (measured by antibody levels), meaning they had been exposed over the years to various pathogens such as the herpes simplex type 1 virus that causes cold sores, were more likely to have cognitive problems than ...
Up until now, the invisibility cloaks put forward by scientists have been fairly bulky contraptions – an obvious flaw for those interested in Harry Potter-style applications.
However, researchers from the US have now developed a cloak that is just micrometres thick and can hide three-dimensional objects from microwaves in their natural environment, in all directions and from all of the observers' positions.
Presenting their study today, 26 March, in the Institute of Physics and German Physical Society's New Journal of Physics, the researchers, from the University of ...
For the first time, the complete genomes of three separate populations of aye-ayes -- a type of lemur -- have been sequenced and analyzed in an effort to help guide conservation efforts. The results of the genome-sequence analyses will be published in an early edition of Proceedings of the National Academy of Sciences online during the week of 25 March 2013. The team of scientists is led by George H. Perry, an assistant professor of anthropology and biology at Penn State University; Webb Miller, a professor of biology and of computer science and engineering at Penn State; ...
Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.
The findings, published in the online Early Edition of the Proceedings of the National Academy of Sciences on March 25, 2013 represent a potential new therapy for treating at least some patients with CLL, the most common type of blood cancer in the United States.
CLL cells express high levels of a cell-surface glycoprotein receptor called CD44. Principal investigator Thomas ...
Limiting the number of continuous hours worked by medical trainees failed to increase the amount of sleep each intern got per week, but dramatically increased the number of potentially dangerous handoffs of patients from one trainee to another, new research from Johns Hopkins suggests. The reductions in work hours also decreased training time, the researchers found.
In 2011, stricter national regulations, reducing the continuous-duty hours of first-year resident physicians from 30 to 16, were put in place with the theory that limiting trainees' work hours would lead them ...
ANN ARBOR, Mich. — At hospitals around the country, young doctors fresh out of medical school help care for patients of all kinds – and work intense, long hours as part of their residency training.
Traditionally, residents were allowed to work more than 24 hours without a break. In 2011, new rules cut back the number of hours they can work consecutively to 16, in the name of protecting patients from errors by sleepy physicians.
But a new study of more than 2,300 doctors in their first year of residency at over a dozen hospital systems across the country raises questions ...
Mild cognitive impairment at the time of Parkinson disease (PD) diagnosis appears to be associated with an increased risk for early dementia in a Norwegian study, according to a report published Online First by JAMA Neurology, a JAMA Network publication.
Patients with PD have an increased risk for dementia (PDD) compared with healthy individuals and researchers sought to examine the course of mild cognitive impairment (MCI) and its progression to dementia in a group of patients with PD. The Norwegian ParkWest study is an ongoing population-based study of the incidence, ...
A review of the available medical literature suggests that data on experience-related outcomes in children's surgery are limited and vary widely in methodologic quality, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
Hospital and surgeon characteristics are often examined in terms of outcomes. Studies in adults have been numerous but the quality and quantity of similar data in children are less consistent, according to the study background.
Jarod P. McAteer, M.D., of Seattle Children's Hospital, Washington, and colleagues ...
Long term treatment by carmustine, a chemical relative of mustard gas and already used to treat some types of brain cancer, can decrease the amount of amyloid β and number of amyloid plaques in a mouse model of Alzheimer's disease. The research is published in Biomed Central's open access journal BMC Medicine.
Alzheimer's disease progressively destroys memory, language, and judgement of affected people. While deaths due to heart disease, stroke and cancer may be decreasing, the number of deaths each year due to Alzheimer's disease is on the increase. Accumulation ...
